Netherlands Centre for One Health (NCOH) aims for an integrated One Health approach to tackle the global risk of infectious diseases. NCOH commits to create durable solutions for this major challenge by bundling world-leading academic top research in the Netherlands in the area of One Health. The antimicrobial resistance research from the Department of Medical Microbiology (dLAB) and Department of Epidemiology (dJulius) is fully integrated within NCOH. In May 2019, NCOH issued its second “OneHealth Magazine”, with several contributions from UMC Utrecht (in particular, interview with PhD student participating in the NCOH PhD programme from UMC Utrecht and an article on antimicrobial resistance in the Netherlands, based on PhD research by Wouter Rottier). For the full magazine, click here.
In a supplemental round of the Infectious Disease Control program of ZonMw (subsidy provider in the field of health research and care innovation), 12 projects with a duration of up to 18 months were approved. Three of these projects went to researchers who are connected to the strategic theme Infection & Immunity at UMC Utrecht.
The awarded projects will all start in 2019 and are expected to be completed in early 2021. All projects are a follow-up to previously awarded larger projects that are at an advanced stage. Internist-infectiologist dr. Jan Jelrik Oosterheert receives no less than two follow-up grants and also prof. dr. Miriam Kretzschmar receives a grant to continue her current research.
Infectious disease control research projects receive ZonMw grant
A rapid diagnostic test have has investigated in a clinical trial in Rwanda with which urinary tract infections (UTIs) can be treated earlier and in a more targeted manner. According to researcher Janneke van de Wijgert (Julius Center), rapid testing for infections can also achieve a great deal of health gain in the Netherlands. Especially in the vulnerable elderly.
Whoever goes to the doctor in the Netherlands with complaints that may indicate an infection, for example an airway infection or a bladder infection, often does not undergo testing to determine whether there is actually an infection and, if so, which infection. Sometimes a doctor will take a sample and send it to a laboratory, but then it takes a few days before the result is known. The doctor usually bases his opinion during the consultation on the complaints of a patient and a physical examination: he has a strong suspicion and makes a "best guess".
Point-of-care testing for rapid diagnosis of UTIs
Dutch hospitals start trial to improve care for people with systemic sclerosis
A new way of working, based on eHealth, should improve the care for people with systemic sclerosis. With an app, patients with systemic sclerosis and their practitioner can exchange data with national experts. UMC Utrecht is working together with other hospitals through this app, which helps to generate the best treatment plan.
The pilot is being carried out by the Arthritis Research and Collaboration Hub (ARCH) network, which was established with the help of the Dutch Arthritis Foundation (ReumaNederland). The network aims to improve the care for people with rare forms of rheumatism (systemic autoimmune diseases).
In his inaugural lecture, Harry Heijerman (professor of pulmonology at UMC Utrecht) argued for more e-health for patients with cystic fibrosis. "More e-health for patients with cystic fibrosis (CF) and a smoother transition from a children's hospital to a hospital for adults is needed." For optimal care. He discussed the developments in care for various lung diseases, but he mainly talked about CF. He argued for a different organization of care to ensure that patients suffer as little as possible from their treatment.
"We can take more burden off from patients"
je telefoon of tablet
om deze pagina te